Repeated low-intensity red light therapy for childhood myopia: a retrospective cohort study
Tan M, Li B, Xu Z, Wu D, Liu J, Tang W, Xu F
American journal of translational research · 1 citation
Review labels
Neutral facts our review recorded about how this study was done. They describe method, never whether we like the result.
How it was studied
- Design
- Cohort study (classified by our AI screen)
- Studied in
- People
- Main outcome
- Health markers and function
Who paid for it
- Funding
- Funding not disclosed
Publication
- Published
- 2025-01-01 · Am J Transl Res · vol. 17 · issue 9 · pp. 6951–6959
- Publisher
- e-Century Publishing Corporation
- Cited
- 2 citations · more than 82% of similar papers · 1.3× the field average
- References
- 0 works
- Access
- Free to read
- Research areas
- Ophthalmology and Visual Impairment Studies · Corneal surgery and disorders · Retinopathy of Prematurity Studies
- Keywords
- Retrospective cohort study, Light therapy, Intervention (counseling), Red light, Cohort study
1 author
From CN
- Meihua Tan · correspondingGanzhou People's Hospital
Abstract
Objectives
To evaluate the efficacy and safety of repeated low-intensity red light (RLRL) therapy in slowing myopia progression and improving accommodative function in children.
Methods
This retrospective cohort study reviewed electronic medical records of 202 myopic children aged 6-12 years treated at Ganzhou People's Hospital between October 2022 and October 2024. Participants were assigned to an RLRL group (n = 101; 650 nm, 1600 lx, 3 min, twice daily) or a control group (n = 101; single-vision spectacles only). Primary outcomes included axial length and spherical equivalent refraction. Secondary outcomes were uncorrected and best-corrected visual acuity, macular choroidal thickness, accommodative amplitude and facility, intraocular pressure (IOP), and corneal endothelial cell density (ECD).
Results
Baseline demographics and ocular characteristics were comparable between groups (all P > 0.05). Up to 12 months, the RLRL group exhibited significantly less axial elongation and myopic refractive progression (P 0.05).
Conclusion
RLRL therapy significantly slowed myopia progression and improved visual and accommodative function in children over 12 months, with no major safety concerns. These findings support RLRL as a promising, safe intervention for pediatric myopia control.
Abstract via Europe PMC. Copyright remains with the authors or publisher.
Community trust
Loading…
How much do you trust this study's findings?
Comments
Sign in to rate, comment on or flag this study.Sign inSomething wrong here?
Flag this study if its information, labels or funding look wrong. An editor reviews every flag.
Sign in to rate, comment on or flag this study.Sign inEducational information about published research. Not medical advice, and not a recommendation to start or stop anything.